Skip to Content
Merck
  • In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.

In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.

Nanoscale (2020-01-03)
Otto K Kari, Joseph Ndika, Petteri Parkkila, Antti Louna, Tatu Lajunen, Anne Puustinen, Tapani Viitala, Harri Alenius, Arto Urtti
ABSTRACT

Methodological constraints have limited our ability to study protein corona formation, slowing nanomedicine development and their successful translation into the clinic. We determined hard and soft corona structural properties along with the corresponding proteomic compositions on liposomes in a label-free workflow: surface plasmon resonance and a custom biosensor for in situ structure determination on liposomes and corona separation, and proteomics using sensitive nanoliquid chromatography tandem mass spectrometry with open-source bioinformatics platforms. Undiluted human plasma under dynamic flow conditions was used for in vivo relevance. Proof-of-concept is presented with a regular liposome formulation and two light-triggered indocyanine green (ICG) liposome formulations in preclinical development. We observed formulation-dependent differences in corona structure (thickness, protein-to-lipid ratio, and surface mass density) and protein enrichment. Liposomal lipids induced the enrichment of stealth-mediating apolipoproteins in the hard coronas regardless of pegylation, and their preferential enrichment in the soft corona of the pegylated liposome formulation with ICG was observed. This suggests that the soft corona of loosely interacting proteins contributes to the stealth properties as a component of the biological identity modulated by nanomaterial surface properties. The workflow addresses significant methodological gaps in biocorona research by providing truly complementary hard and soft corona compositions with corresponding in situ structural parameters for the first time. It has been designed into a convenient and easily reproducible single-experiment format suited for preclinical development of lipid nanomedicines.

MATERIALS
Product Number
Brand
Product Description

Avanti
18:0 Lyso PC, 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform
Avanti
18:0 Lyso PC, Avanti Research - A Croda Brand
Avanti
16:0 PC (DPPC), Avanti Research - A Croda Brand
Avanti
18:0 PC (DSPC), Avanti Research - A Croda Brand
Avanti
16:0 PC (DPPC), Avanti Research - A Croda Brand
Avanti
18:0 PC (DSPC), Avanti Research - A Croda Brand
Avanti
18:0 PE, Avanti Research - A Croda Brand
Avanti
18:0 PEG2000 PE, Avanti Research - A Croda Brand
Avanti
18:0 PEG2000 PE, Avanti Research - A Croda Brand 880120C